Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
Conditions: Acute Coronary Syndrome (ACS) Interventions: Device: Drug-coated balloon; Drug: Guideline-directed medical treatment Sponsors: Harbin Medical University; Shanghai Shenqi Medical Technology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Clinical and Angiographic Outcomes of Post-drug-coated Balloon Angioplasty in Native Coronary Lesions
Conditions: Coronary Artery Disease Interventions: Device: DCB Angioplasty Sponsors: National Institute of Cardiovascular Diseases, Bangladesh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Drug-coated Balloon Treatment in Coronary Lesions
Conditions: Drug-coated Balloon Interventions: Device: Angioplasty Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Bail-Out Stenting and Target-vessel Failure After Drug Coated Balloon Coronary percutaneouS Angioplasty for de Novo Lesions
Conditions: DCB; De Novo Stenosis; PCI Sponsors: IRCCS Azienda Ospedaliero-Universitaria di Bologna Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Balloon Pulmonary Angioplasty vs. Combined Approach With Pulmonary Artery Denervation in CTEPH: Effectiveness Comparison
Conditions: Chronic Thromboembolic Pulmonary Hypertension Interventions: Procedure: Balloon Pulmonary Angioplasty combined with Pulmonary Artery Denervation; Procedure: Balloon Pulmonary Angioplasty with Sham Pulmonary Artery Denervation Sponsors: Boris Dzudovic; Military Medical Academy, Belgrade, Serbia; Galen Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)
Conditions: Coronary Artery Disease Interventions: Device: Mozec ™ SEB Sirolimus Eluting Rx PTCA Balloon Dilatation Catheter Sponsors: University National Heart Hospital; Meril Life Sciences Pvt. Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Conditions: Arterial Disease of Legs Interventions: Device: MagicTouch PTA Sirolimus drug coated balloon; Device: Placebo balloon angioplasty Sponsors: Concept Medical Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Assessment of Cutting-Balloon Angioplasty With EES in the Treatment of CCL Guided by IVUS
Conditions: Coronary Artery Disease Interventions: Device: Wolverine cutting balloon; Device: Non-compliant balloon Sponsors: Soonchunhyang University Hospital; Boston Scientific Corporation; Eulji University; The Catholic University of Korea; Hanil General Hospital, Korea Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
Assessment of Cutting-Balloon Angioplasty With Everolimus-Eluting Stent(EES) in the Treatment of Coronary Calcified Lesion(CCL) Guided by Intravascular Ultrasonography(IVUS)
Conditions: Coronary Artery Disease Interventions: Device: Wolverine cutting balloon; Device: Non-compliant balloon Sponsors: Soonchunhyang University Hospital; Boston Scientific Corporation; Eulji University; The Catholic University of Korea; Hanil General Hospital, Korea Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
A RanDomized Controlled Trial of the Drug Eluting TEmporary Spur StEnt System vs PERcutaneous Balloon Angioplasty for the TReatment of CriTical Limb Ischemia
Conditions: Critical Limb Ischemia Interventions: Device: Drug Eluting Temporary Spur Stent System; Device: Percutaneous Transluminal Balloon Angioplasty Sponsors: ReFlow Medical, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia
Conditions: Critical Limb Ischemia Interventions: Device: Drug Eluting Temporary Spur Stent System; Device: Percutaneous Transluminal Balloon Angioplasty Sponsors: ReFlow Medical, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
BPA in CTEPD Without PH
Conditions: Chronic Thromboembolic Disease Interventions: Procedure: Balloon Pulmonary Angioplasty (BPA) Sponsors: Amsterdam UMC, location VUmc; Trombosestichting Nederland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
The SIR-POBA Shunt Trial
Conditions: Arteriovenous Fistula Stenosis Interventions: Radiation: Balloon Angioplasty Sponsors: Paracelsus Medical University; MedAlliance Swiss Medical Technology Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
The SIR-POBA Bypass Trial
Conditions: Peripheral Arterial Occlusive Disease; Bypass Complication; Femoropopliteal Artery Occlusion; Femoropopliteal Stenosis; Critical Limb-Threatening Ischemia; Claudication, Intermittent Interventions: Procedure: Balloon Angioplasty Sponsors: Paracelsus Medical University; MedAlliance Swiss Medical Technology Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula
Condition: Peripheral Arterial Disease Interventions: Procedure: Rapamycin drug balloon angioplasty; Procedure: Paclitaxel drug balloon angioplasty Sponsor: Shanghai Bomaian Medical Technology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
